Clean Energy and Health Expenditure in an African Setting: A Socioeconomic Analysis of Household Costs and Willingness to Pay [0.03%]
Davies Adeloye,Wale O Ogunleye,Boni M Ale et al.
Davies Adeloye et al.
Background: Climate vulnerability in sub-Saharan Africa, including Nigeria, has heightened concern about household energy transitions and associated health and economic impacts. Despite clean fuel initiatives, uncertainty...
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population [0.03%]
Tariku J Beyene,Vincent J Willey,Malvika Venkataraman et al.
Tariku J Beyene et al.
Background: Babies born with congenital pulmonary valve disease (CPVD) face a lifetime burden of disease and significant medical expense beginning in their first year of life. ...
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis [0.03%]
Efgartigimod治疗全身型重症肌无力给加拿大政府带来的财政影响分析报告
Ana Teresa Paquete,Mark P Connolly,Cynthia Qi et al.
Ana Teresa Paquete et al.
Background: Generalized myasthenia gravis (gMG) severely impacts activities of daily living. Productivity losses and the need for care can impact household finances and consequently government public accounts. This study adopts a government...
Modeling Financial Insolvency and Income Loss Insurance in Head and Neck Cancer [0.03%]
头颈癌的财务困境和收入损失保险的模拟研究
Ana V Araujo,Murray J Bartho,Garren M I Low et al.
Ana V Araujo et al.
Background: Head and neck cancer (HNC) carries high morbidity, and its treatment can be functionally devastating, impacting a patient's ability to work. While most patients have medical insurance benefits, studies on the ...
Environmental Impact of Pentaspline Pulsed Field Ablation-Global Warming or Arctic Front? [0.03%]
ペンタスプラインPFAとアリcticフロントPFAの環境への影響は?
Peter Calvert,Vishal Luther,Dhiraj Gupta
Peter Calvert
Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV [0.03%]
经抗逆转录病毒治疗的HIV感染者的治疗转换疗法
Benjamin Chastek,Uche Mordi,Mary J Christoph et al.
Benjamin Chastek et al.
Background: HIV requires lifelong continuous antiretroviral therapy (ART) to prevent morbidity and mortality and to reduce onward transmission. People with HIV (PWH) may switch ART regimens for various clinical and noncli...
Cost-Effectiveness Analysis of Trastuzumab-Emtansine as Adjuvant Therapy for HER2-Positive Early Breast Cancer with Residual Invasive Disease in Colombia [0.03%]
赫赛莱治疗HER2阳性早期乳腺癌残留病灶的经济学分析研究报告——哥伦比亚地区
Daniel Samacá-Samacá,Diego Ballén,Milton Lombana et al.
Daniel Samacá-Samacá et al.
Background: Patients with HER2-positive (HER2+) breast cancer (BC) who have residual invasive disease after neoadjuvant therapy remain at a significantly increased risk of recurrence. Updated results from the KATHERINE tr...
The Paradox of Life Extension with Traditional Cost-Effectiveness Analysis: A Case Study with Duchenne Muscular Dystrophy [0.03%]
成本效益分析在延长寿命的药物研发中的局限性——以杜氏肌营养不良症为例研究 Kosten-Nutzen-Analyse bei der Entwicklung von Medikamenten zur Lebenserwartungsverlängerung: Eine Fallstudie zum Duchenne-Muskeldystrophiemodell
Lauren Sedita,Alexa Klimchak,Eleanor Perfetto et al.
Lauren Sedita et al.
Background: Traditional quality-adjusted life-year (QALY)-based cost-effectiveness analyses (CEAs) may inadvertently penalize treatments extending survival in populations with disabilities. Duchenne muscular dystrophy (DM...
Cost-Effectiveness of Continuously Diffused Oxygen Therapy Compared with Negative-Pressure Wound Therapy [0.03%]
持续氧疗法与负压伤口治疗的经济性比较研究
Matthew Mercurio,Lawrence A Lavery,Animesh Agarwal et al.
Matthew Mercurio et al.
Background: Continuous diffusion of oxygen (CDO) to wounds has demonstrated better effectiveness in healing wounds than negative-pressure wound therapy (NPWT). However, there is limited evidence regarding the cost-effecti...
Trial Interviews to Explore Glycogen Storage Disease Type Ia Patient Experiences Following Gene Therapy [0.03%]
试验性访谈以探索I型糖原贮积病患者接受基因治疗后的体验
Diane M Turner-Bowker,Jessica Butler,Shayna Egan et al.
Diane M Turner-Bowker et al.
Background: Glycogen storage disease type Ia (GSDIa) is a rare, inherited, autosomal recessive deficiency of glucose-6-phosphatase (G6Pase), an enzyme necessary in glycogenolysis and gluconeogenesis. To maintain normal bl...